Compare · MASI vs POCI
MASI vs POCI
Side-by-side comparison of Masimo Corporation (MASI) and Precision Optics Corporation Inc. (POCI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MASI and POCI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- MASI is the larger of the two at $9.42B, about 179.4x POCI ($52.5M).
- Over the past year, MASI is up 12.5% and POCI is down 2.8% - MASI leads by 15.3 points.
- MASI has hit the wire 1 time in the past 4 weeks while POCI has been quiet.
- MASI has more recent analyst coverage (24 ratings vs 0 for POCI).
- Company
- Masimo Corporation
- Precision Optics Corporation Inc.
- Price
- $179.96+0.00%
- $4.75-2.16%
- Market cap
- $9.42B
- $52.5M
- 1M return
- +0.93%
- -12.11%
- 1Y return
- +12.51%
- -2.76%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2007
- News (4w)
- 1
- 0
- Recent ratings
- 24
- 0
Masimo Corporation
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
Latest MASI
- SEC Form 15-12G filed by Masimo Corporation
- Director Solomon Darlene J. S. returned $542,700 worth of shares to the company (3,015 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Scannell Timothy J returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Lane Wendy E returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director by deputization Politan Capital Management Lp
- Director by deputization Politan Capital Management Lp returned $826,357,140 worth of shares to the company (4,590,873 units at $180.00) (SEC Form 4)
- Chairman of the Board Brennan Michelle returned $1,675,620 worth of shares to the company (9,309 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SVP, Chief Accounting Officer Hataishi Paul returned $2,397,060 worth of shares to the company (13,317 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- EVP, Operations Sampath Anand returned $6,102,180 worth of shares to the company (33,901 units at $180.00), closing all direct ownership in the company (SEC Form 4) to cover taxes
- SEC Form 4 filed by Chief Commercial Officer Meehan Greg Allen (for tax liability)
Latest POCI
- Precision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
- Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
- Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
- SEC Form 10-Q filed by Precision Optics Corporation Inc.
- New insider Needham Investment Management Llc claimed ownership of 3,341,100 shares (SEC Form 3)
- Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
- Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program
- SEC Form 3 filed by new insider Needham Investment Management Llc
- SEC Form 4 filed by Coll Wayne M
- SEC Form 4 filed by Traut Joseph